Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and
affects patients of all genders, races, ethnicities, and socioeconomic status. While the …

Despite improved screening and surveillance guidelines, significant race/ethnicity‐specific
disparities in hepatocellular carcinoma (HCC) continue to exist and disproportionately affect …

Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma Page
1 353 |CliniCal liver Disease, vOl 17, nO 5, MaY 2021 An Official Learning Resource of AASLD …

Background Hepatocellular carcinoma (HCC) disproportionately impacts racial and ethnic
minorities and patients with lower socioeconomic status. These social determinants of health …

Hepatocellular carcinoma (HCC) is a leading cause of death in patients with cirrhosis and
has a rising mortality rate in the United States. 1 Racial and ethnic minorities experience a …

Health disparities in diagnosis and treatment of hepatocellular carcinoma Page 1 REVIEW
Health Disparities in Diagnosis and Treatment of Hepatocellular Carcinoma Amy K. Kim, MD …

Background & Aims Racial and ethnic minorities are reported to have higher mortality
related to hepatocellular carcinoma (HCC) than non-Hispanic whites. However, it is not clear …

Background Racial/ethnic and socioeconomic disparities are assumed to negatively affect
treatment and outcomes for hepatocellular carcinoma (HCC). Our aim was to investigate the …

Background: Race, gender, insurance status, and income play important roles in predicting
health care outcomes. However, the impact of these factors has yet to be fully elucidated in …

There are significant ethnic disparities in incidence, tumor stage, curative therapy receipt,
and survival among patients with hepatocellular carcinoma (HCC) in the US. While previous …